Inspire Medical Systems, Inc. (INSP)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Biotech / Pharmasrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-09-29. ClinicalTrials.gov
Dilution Risk
LOW DILUTION RISKDilution score: 24/100 (LOW), cash runway not available
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 14.58% of float, squeeze risk: MODERATE
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- Inspire Medical (INSP): How Much Optimism Is Baked Into This Medtech Stock?
- Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
- Inspire Medical Systems (INSP) Stock Could Be A Bargain On Cash Flow
- Inspire Medical Systems (INSP) Faces A Rebound Question As Fair Value Stays In Focus
- Inspire Medical Systems (INSP) Stock Could Be 14% Undervalued On Cash Flow
- Why Inspire Medical Systems (INSP) Stock Is Up Today
- Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q2 Earnings?
- Zacks Industry Outlook Medical Systems, American Well and Butterfly Network
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Inspire Medical Systems, Inc..
Full INSP Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.